DexCom, Inc. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↑+13.1% +$146M
$1.26B
Cost of Revenue↑+2.0% +$9M
$467M
Gross Profit↑+20.9% +$137M
$793M
R&D↑+6.2% +$9M
$148M
SG&A↓-1.8% -$6M
$322M
D&A↑+12.8% +$7M
$65M
Operating Income↑+71.0% +$134M
$323M
EBITDA↑+57.4% +$142M
$388M
Interest Expense↓-16.2% -$600K
$3M
Interest Income
—
Other Income/Expense↓-20.3% -$5M
$21M
Pretax Income↑+61.2% +$129M
$341M
Tax Provision↑+23.2% +$14M
$73M
Net Income↑+76.2% +$116M
$267M
Gross Margin↑+4.0pts
62.9%
Operating Margin↑+8.7pts
25.6%
Net Margin↑+7.6pts
21.2%
Effective Tax Rate↓-6.7pts
21.5%
Deferred Tax Assets↓-40.4% -$6M
$9M
Deferred Tax Liabilities
—
DTA Valuation Allowance
—
ETR (Continuing Operations)
23.2%
ETR Federal Statutory
21.0%
ETR State + Local (pp)
1.5%
Operating Lease Cost↓-6.4% -$900K
$13M
Revenue YoY Variation↑+5.5pts
13.1%
Income YoY Variation↑+83.9pts
71.0%
Revenue QoQ Variation↓-7.8pts
4.2%
Income QoQ Variation↑+8.9pts
33.2%